Summary | SEOUL Celltrion Inc., which sells a cheap version of
a top-selling rheumatoid arthritis drug in Europe, is now
setting its sights on the U.S., the world's biggest
pharmaceutical market.Stanley Hong, chief executive of the
South Korean company's distribution and marketing unit,
Celltrion Healthcare Co., said in a recent interview it will ...
a top-selling rheumatoid arthritis drug in Europe, is now
setting its sights on the U.S., the world's biggest
pharmaceutical market.Stanley Hong, chief executive of the
South Korean company's distribution and marketing unit,
Celltrion Healthcare Co., said in a recent interview it will ...
blogs.wsj.com | 01 April 2015